Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

NCT02178475 · clinicaltrials.gov ↗
COMPLETED
Status
943
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Amgen